Sunday, April 11, 2021

Covid-19: A view from the community pharmacy frontline, one year on

By Raj Aggarwal It was just over 12 months ago when Prime Minister Boris Johnson announced that we would all go into lockdown on the 23rd of...

VIEWPOINT: NHS integration needs to go further

  The Covid-19 pandemic has undoubtedly given pharmacists a greater profile but they are still often not considered as an integral part of the NHS,...

REALITY CHECK: Dealing with racism

  Harpreet Guraya recalls the everyday racism she faces on the frontline of community pharmacy and argues for better ethnic representation in healthcare to address...

INNOVATION HUB: Clinicians need to find their why

  In the first of a new series of exclusive articles, Faheem Ahmed explains how having a deeper sense of purpose can help build a...

Generics: Known unknowns and unknown unknowns

  Two senior executives record the resilience shown by the generics industry in a year marked by Brexit uncertainties and pandemic challenges… Business as usual By Peter...

How about pharmacists’ mental health?

  Danielle Hunt explains why encouraging better mental health awareness and practice within the sector is crucial in helping pharmacists deal with high levels of...

Why invest in ‘mental wealth’

  As pharmacists navigate a third lockdown with unprecedented demand for their services, pharmacy teams are likely to face prolonged periods of stress, writes Harpreet...

Best of both worlds

  Jon Higham explains why community pharmacies will have to continue evolving despite their crucial role in the UK’s Covid-19 vaccination programme… With hundreds of community...

The cannabis conundrum

  Reece Samani says the UK could take the lead in bringing safe and efficacious medical cannabis products to the market by investing in R&D…   On...

Pharmacy post Brexit

  Britain’s exit from the EU has caused significant change but much will depend on how ministers use their powers when the Medicines and Medical...